Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/08/2005US6962777 VLP-containing compositions produced express conformational, neutralizing epitopes and have high homogeneity and therefore comprise effective diagnostic and prophylactic agents for diagnosis or prevention of papillomavirus infections
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/08/2005CA2239005C Production of ammonium acrylate
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/07/2005CA2466995A1 Method of evaluating the pathogenic potential of a strain of listeria
11/06/2005CA2504403A1 Prognostic for hematological malignancy
11/03/2005WO2005103713A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103709A1 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor fksg79 (fksg79)
11/03/2005WO2005103706A1 Reagents, devices and methods for proteomic analysis with applications including diagnostics and vaccines
11/03/2005WO2005103705A2 Chemoselective fluorogenic molecular linkers and methods of their preparation and use
11/03/2005WO2005103695A1 Gene detection method and gene detection apparatus
11/03/2005WO2005103692A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103685A1 Auxiliary tool for examination of biopsy specimen
11/03/2005WO2005103682A1 Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension
11/03/2005WO2005103681A1 Diagnostics and therapeutics for diseases associated with endothelin receptor type b-like protein 1(etbr-lp-1)
11/03/2005WO2005103303A2 Apparatus and method for transdermal delivery of multiple vaccines
11/03/2005WO2005103302A2 Mutant viral nucleic acids and vaccine containing same
11/03/2005WO2005103301A2 Corn event mir604
11/03/2005WO2005103300A2 Pattern recognition method for diagnosis of systemic autoimmune diseases
11/03/2005WO2005103299A2 Rnai-based target identification and validation
11/03/2005WO2005103298A2 Method for detecting ncrna
11/03/2005WO2005103297A1 METHODS AND COMPOSITIONS RELATED TO MODULATION OF p22phox
11/03/2005WO2005103296A2 Global gene expression analysis of human bronchial epithelial cells exposed to cigarette smoke, smoke condensates, or components thereof
11/03/2005WO2005103295A2 Method and tools for analysis of nucleic acids
11/03/2005WO2005103294A1 Genomic microarray for detecting lactic acid bacteria and method for diagnosing lactic acid bacteria using it
11/03/2005WO2005103293A1 K-ras oligonucleotide microarray and method for detecting k-ras mutations employing the same
11/03/2005WO2005103292A1 Method of monitoring gibberellin and abscisic acid synthesis during barley milling
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103290A1 Diagnostics and therapeutics for diseases associated with aspartyl aminopeptidase (dnpep)
11/03/2005WO2005103289A1 The use of mitochondrial point mutations as sensitive clonal markers
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103286A1 Method of measuring activity of homocysteine thiolactone hydrolase
11/03/2005WO2005103285A2 Systems and methods for indicating oxidation of consumer products
11/03/2005WO2005103284A2 Trend analysis and statistical process control using multitargeted screening assays
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103282A1 Method of measuring active oxygen
11/03/2005WO2005103281A2 Platelet biomarkers for the detection of disease
11/03/2005WO2005103277A1 Dry amplification reagent mixture for polymerase chain reaction and the technique of pcr analysis
11/03/2005WO2005103266A1 Cry1f and cry1ac transgenic cotton lines and event-specific identification thereof
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103251A2 Cancer specific promoters
11/03/2005WO2005103249A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
11/03/2005WO2005103248A1 Mutated glucose dehydrogenase
11/03/2005WO2005103246A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005103243A2 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
11/03/2005WO2005103240A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)
11/03/2005WO2005103162A1 Fluorescent labeled nucleotide derivatives
11/03/2005WO2005102526A1 Devices and methods for collection, storage and transportation of biological specimens
11/03/2005WO2005102396A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
11/03/2005WO2005102379A2 Nucleic acid based assays for identification of fc receptor polymorphisms
11/03/2005WO2005102176A1 Xanthene dyes
11/03/2005WO2005102154A2 Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
11/03/2005WO2005102040A1 Tlr ligand and il-1 response-injured animal model
11/03/2005WO2005102039A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005088306A3 Biologically-active dna-binding sites and related methods
11/03/2005WO2005085873A3 Detection of preterm labour
11/03/2005WO2005085869A3 Determination of analyte characteristics based upon binding properties
11/03/2005WO2005085474A3 Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
11/03/2005WO2005085472A3 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/03/2005WO2005080605A3 Methods and kits for analyzing polynucleotide sequences
11/03/2005WO2005080602A3 Immunological detection of rna:dna hybrids on microarrays
11/03/2005WO2005079822A3 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
11/03/2005WO2005072087A3 System and methods for nucleic acid and polypeptide selection
11/03/2005WO2005068635A3 Test system for the identification of antifungal agents
11/03/2005WO2005066370A3 Methods for determining nucleotide sequence information
11/03/2005WO2005066363A3 Cancer specific gene ccndbp1
11/03/2005WO2005066211A3 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
11/03/2005WO2005065290A3 Metallization of nucleic acids by metal sols, and uses thereof
11/03/2005WO2005054512A3 Method to diagnose or screen for type 1 diabetes mellitus
11/03/2005WO2005051295A3 Asymmetrically branched polymer conjugates and microarray assays
11/03/2005WO2005042781A3 Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
11/03/2005WO2005042764A3 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
11/03/2005WO2005035718A3 Biderectional promoters for small rna expression
11/03/2005WO2005028620A3 Histone modifications as binary switches controlling gene expression
11/03/2005WO2005026735A3 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
11/03/2005WO2005024695A3 Methods for encoding non-biological information on microarrays
11/03/2005WO2005024062A3 Method for the identification of attenuating lesions in pathogens
11/03/2005WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
11/03/2005WO2005019831B1 Methods for reducing complexity of a sample using small epitope antibodies
11/03/2005WO2005019433A3 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
11/03/2005WO2005007890A3 Means and methods for detecting a risk of infarction related to atherosclerosis
11/03/2005WO2004113556A3 Assay and kits for detecting protein binding
11/03/2005WO2004093646A3 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/03/2005WO2004080285A3 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
11/03/2005WO2004072614A3 Method and apparatus for detecting an analyte
11/03/2005WO2004072240A8 Antiplasmin cleaving enzyme
11/03/2005WO2004058985A3 Rapid direct sequence analysis of multi-exon genes
11/03/2005WO2004057016A3 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN
11/03/2005WO2004018647A3 Methods and compositions for categorizing patients
11/03/2005WO2003062173A8 Alanine 2,3- aminomutase
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050246799 Receptors for hypersensitive response elicitors and uses thereof
11/03/2005US20050246794 Functional and hyperfunctional siRNA
11/03/2005US20050246784 Method for identifying herbicidally active substances
11/03/2005US20050246106 Methods and systems for identifying genes, splice variants, and transcripts using an evidence mapping approach
11/03/2005US20050245798 Device and system for humor component detection
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245728 Novel purified polypeptides from Pseudomonas aeruginosa
11/03/2005US20050245726 Detecting the phosphorylation activity of protein kinases using a substrate compound with hydrophobic moieties that integrate the compound into a micelle, non-proteinaceous fluorescent moieties (fluorescent dyes), and an enzyme recognition moiety